Vanishing white matter disease with mutations in EIF2B5 gene

Suvasini Sharma1, Mohemmed Ajij, Varinder Singh

  • 1Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, 110001, India, sharma.suvasini@gmail.com.

Indian Journal of Pediatrics
|September 19, 2014
PubMed

Insights

Vanishing white matter disease, a rare genetic disorder, was diagnosed in an 18-month-old girl. Genetic testing confirmed mutations in the EIF2B5 gene, explaining her loss of developmental milestones.

Area of Science:

  • Pediatric Neurology
  • Neurogenetics
  • Molecular Medicine

Background:

  • Vanishing white matter disease (VWMD) is a severe inherited leukoencephalopathy.
  • It typically presents in early childhood with progressive neurological decline.
  • VWMD is caused by mutations in genes encoding subunits of the eukaryotic initiation factor 2B (eIF2B).

Observation:

  • An 18-month-old female presented with sudden loss of attained milestones following a febrile illness.
  • Brain MRI revealed extensive white matter rarefaction and cystic degeneration, characteristic of VWMD.
  • The patient exhibited a febrile illness preceding the neurodevelopmental regression.

Findings:

  • Genetic analysis identified compound heterozygous mutations in the EIF2B5 gene.
  • These mutations confirmed the diagnosis of vanishing white matter disease.
  • The specific mutations found were novel or previously uncharacterized.

Implications:

  • This case highlights the importance of early recognition of VWMD based on clinical presentation and neuroimaging.
  • Genetic confirmation using EIF2B5 gene analysis is crucial for accurate diagnosis and genetic counseling.
  • Understanding genotype-phenotype correlations in VWMD can aid in predicting disease progression and potential therapeutic targets.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
16
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.1K
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
9
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
133.3K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.8K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
7